v3.26.1
Unaudited Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Current Assets    
Cash and cash equivalents $ 1,364 $ 1,263
Trade receivables - third party and affiliates 1,288 922
Non-trade receivables, net 581 545
Inventories 2,305 2,220
Assets held for sale 0 492
Other assets 257 251
Total current assets 5,795 5,693
Investments in affiliates 1,233 1,252
Property, plant and equipment, net 4,807 5,076
Operating lease right-of-use assets 417 359
Deferred income taxes 1,325 1,359
Other assets 605 601
Goodwill [1] 4,151 4,171
Intangible assets, net 3,075 3,184
Total assets 21,408 21,695
Current Liabilities    
Short-term borrowings and current installments of long-term debt - third party and affiliates 1,311 1,204
Trade payables - third party and affiliates 1,485 1,279
Liabilities held for sale 0 75
Other liabilities 1,106 1,049
Income taxes payable 104 76
Total current liabilities 4,006 3,683
Long-term debt, net of unamortized deferred financing costs 10,696 11,394
Deferred income taxes 458 512
Uncertain tax positions 211 208
Benefit obligations 321 344
Operating lease liabilities 317 265
Other liabilities 811 817
Commitments and Contingencies
Shareholders' Equity    
Common stock, $0.0001 par value, 400,000,000 shares authorized (2026: 171,036,104 issued and 2025: 170,918,221 issued) 0 0
Treasury stock, at cost (5,480) (5,482)
Additional paid-in capital 450 431
Retained earnings 10,039 9,876
Accumulated other comprehensive income (loss), net (842) (776)
Total Celanese Corporation shareholders' equity 4,167 4,049
Noncontrolling interests 421 423
Total equity 4,588 4,472
Total liabilities and equity $ 21,408 $ 21,695
[1] Includes accumulated impairment losses of $2.7 billion in the Engineered Materials segment.